Last reviewed · How we verify
NCT06599034
Strategies to Increase Adherence to Physical Activity in a Phase III Cardiac Rehabilitation Program
trial in Ischaemic Heart Diseases in 70 participants. Completed in 1 July 2024.
1 January 2023
Quick facts
| Lead sponsor | Hospital de Manises |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 70 |
| Start date | 4 October 2022 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 July 2024 |
| Sites | 1 location across Spain |
Conditions studied
- Ischaemic Heart Diseases — all drugs for Ischaemic Heart Diseases →
Sponsor
Hospital de Manises
Who can join
Adults 18 to 70, any sex, with Ischaemic Heart Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study consists of a randomised clinical trial of two parallel groups conducted in patients with ischaemic heart disease after completing phase II of Cardiac Rehabilitation (RHBC) at the Centro de Especialidades Mislata (CEM),Hospital Manises. The objective is to assess adherence to structured and unstructured physical activity in the long term (6 and 12 months). In addition to the usual recommendations in the Control Group (CG), a motivational programme will be added to the Intervention Group (IG), which will consist of establishing an individualised exercise plan reviewed monthly, in addition to maintaining continuous contact with the physiotherapist.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06599034
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Hospital de Manises trials
Trials by the same sponsor.
- NCT07265492 — UDOPAL Study: Home-Based Interventional Approach to Pain Management in Home-Hospitalized Patients · not yet recruiting
- NCT03669029 — Optimization of Golimumab Treatment in Ulcerative Colitis · Phase 4 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06599034 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital de Manises
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06599034.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing